IN2012DE00193A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00193A
IN2012DE00193A IN193DE2012A IN2012DE00193A IN 2012DE00193 A IN2012DE00193 A IN 2012DE00193A IN 193DE2012 A IN193DE2012 A IN 193DE2012A IN 2012DE00193 A IN2012DE00193 A IN 2012DE00193A
Authority
IN
India
Prior art keywords
layers
drug
situ
polymer
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Vivek Kumaravel
Kuamr Fanda Anuj
Krishna Murali
Sharma Ravish
Singh Bakshi Kanwarpreet
Barat Singh Romi
Kumar Singla Ajay
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to EP13709547.7A priority Critical patent/EP2806861A1/en
Priority to AU2013213317A priority patent/AU2013213317B2/en
Priority to PCT/IB2013/050584 priority patent/WO2013111070A1/en
Priority to IN193DE2012 priority patent/IN2012DE00193A/en
Priority to CA2862469A priority patent/CA2862469A1/en
Priority to US14/373,603 priority patent/US20140377347A1/en
Priority to ZA2014/05499A priority patent/ZA201405499B/en
Publication of IN2012DE00193A publication Critical patent/IN2012DE00193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN193DE2012 2012-01-23 2013-01-23 IN2012DE00193A (enExample)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP13709547.7A EP2806861A1 (en) 2012-01-23 2013-01-23 In-situ multilayered tablet technology
AU2013213317A AU2013213317B2 (en) 2012-01-23 2013-01-23 In-situ multilayered tablet technology
PCT/IB2013/050584 WO2013111070A1 (en) 2012-01-23 2013-01-23 In-situ multilayered tablet technology
IN193DE2012 IN2012DE00193A (enExample) 2012-01-23 2013-01-23
CA2862469A CA2862469A1 (en) 2012-01-23 2013-01-23 In-situ multilayered tablet technology
US14/373,603 US20140377347A1 (en) 2012-01-23 2013-01-23 In-situ multilayered tablet technology
ZA2014/05499A ZA201405499B (en) 2012-01-23 2014-07-25 In-situ multilayered tablet technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN193DE2012 IN2012DE00193A (enExample) 2012-01-23 2013-01-23

Publications (1)

Publication Number Publication Date
IN2012DE00193A true IN2012DE00193A (enExample) 2015-06-12

Family

ID=47884433

Family Applications (1)

Application Number Title Priority Date Filing Date
IN193DE2012 IN2012DE00193A (enExample) 2012-01-23 2013-01-23

Country Status (7)

Country Link
US (1) US20140377347A1 (enExample)
EP (1) EP2806861A1 (enExample)
AU (1) AU2013213317B2 (enExample)
CA (1) CA2862469A1 (enExample)
IN (1) IN2012DE00193A (enExample)
WO (1) WO2013111070A1 (enExample)
ZA (1) ZA201405499B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
TR201717134A2 (tr) * 2016-12-07 2018-07-23 Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi Ağrı Ve Enflamasyonun Hızlı Tedavisi İçin Diklofenak Ve H2 Reseptör Antagonistlerinin Çabuk Salımlı Oral Kombinasyonları

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1188212B (it) 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5221278A (en) 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
IT1256393B (it) 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
IT1265240B1 (it) 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US5783212A (en) 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282650B1 (it) 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6096341A (en) * 1998-10-30 2000-08-01 Pharma Pass Llc Delayed release tablet of bupropion hydrochloride
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
EP1372614A4 (en) * 2001-03-16 2007-10-31 Andrx Pharmaceuticals Llc SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE
AU2002242676B2 (en) * 2002-01-16 2008-05-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
GB0319874D0 (en) * 2003-08-22 2003-09-24 Glaxo Group Ltd Novel formulation
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
PT1781260E (pt) * 2004-08-13 2010-12-20 Boehringer Ingelheim Int Formulação em comprimido de libertação prolongada contendo pramipexole ou um seu sal farmaceuticamente aceitável, um método para a preparação do mesmo e sua utilização
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
KR100885029B1 (ko) 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제

Also Published As

Publication number Publication date
EP2806861A1 (en) 2014-12-03
US20140377347A1 (en) 2014-12-25
AU2013213317B2 (en) 2016-06-30
WO2013111070A1 (en) 2013-08-01
AU2013213317A1 (en) 2014-08-14
ZA201405499B (en) 2015-11-25
CA2862469A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
EP2644113A3 (en) Tissue thickness compensator comprised of a plurality of materials
EP3099645A4 (en) Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
BRPI1014320A2 (pt) comprimido de droga, dispositivo de dispensação de droga implantável, método para produzir um comprimido de dorga sólido, forma de dosagem de droga.
JP2014520248A5 (enExample)
GB2605027B (en) Systems and methods for immobilizing extracellular matrix material on organ on chip, multilayer microfluidics microdevices, and three-dimensional cell culture
MX356930B (es) Compensador de grosor de tejido que comprende una pluralidad de materiales.
AP2014008004A0 (en) Multilayer pipeline in a polymer material, device for manufacture of the multilayer pipeline and a method for manufacturing the multilayer pipeline
EP3020754A4 (en) Composite layer material, method for manufacturing membrane, and method for manufacturing layered body
BR112015010582A2 (pt) método para formação e subsequente secagem de um material compósito compreendendo um polissacarídeo nanofibrilado".
WO2011119325A3 (en) Composite layer
WO2013192411A3 (en) Patient support systems and methods of use
WO2014106001A3 (en) Dual specific binding proteins having a receptor sequence
PL2707212T3 (pl) Tabletkarka rotacyjna z wylotem tabletek, wylot tabletek dla tej tabletkarki rotacyjnej oraz sposób wytwarzania tabletek w tabletkarce rotacyjnej
IL236846A0 (en) Menosid multimers, a process for their preparation and their use as drugs
CL2015001613A1 (es) Electrodos impregnados para desionización capacitiva, proceso para su preparación y aparato para emplear dichos electrodos.
ZA201400375B (en) A multilayer film,packages comprising the multilayer film,and processes for making
SI3316867T1 (sl) Tablete s takojšnjim sproščanjem, ki vsebujejo zdravilo in postopek za pripravo tablet
MX2014014915A (es) Membranas termoplasticas que incluyen polimero con funcionalidad de isocianato reactivo.
SG11202004458VA (en) Multilayer composite with catalytic mixed matrix membrane layer
EP3230064A4 (en) A multilayer structure, a laminate comprising the same and articles comprising the laminate
EP3284722A4 (en) Layered double hydroxide, layered double hydroxide dense film, and composite material
GB201706783D0 (en) Composite layers, methods for their manufacture and uses thereof
EP2886339A4 (en) RESIN FOIL, CARRIER BODY WITH A RESIN LAYER, LAMINATE PLATE AND METAL CASSED LAMINATE PLATE
CL2015000857A1 (es) Una composicion farmaceutica que consiste en una primera capa que comprende metformina y una segunda capa que comprende gemigliptina; su metodo de preparacion, util para la prevencion y el tratamiento de la diabetes.
BR112012021092A2 (pt) material com múltiplas camadas, artigo e método para fabricação de um material com múltiplas camadas